Block 1 Drugs Flashcards

1
Q

Antacids:

Drugs

Mechanism of Action

Uses

Side effects

A
  • Aluminium hydroxide and magnesium hydroxide (Maalox)
  • Calcium carbonate and magnesium carbonate (Rennie)

​Buffer gastric acid to raise pH

Used in:

  • Heartburn and indigestion
  • Acid reflux

Side effects:

  • Aluminium can cause constipation
  • Magnesium can cause diarrhoea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Alginates and Antacids:

Drugs

MoA

Uses

A

Sodium alginate with sodium bicarbonate and calcium carbonate

Anionic polysaccharides that form viscous gel upon binding with water which floats on top of stomach contents, reducing reflux symptoms & protecting oesophageal mucosa

Also increases viscosity of stomach contents to reduce acid reflux.

Used in:

  • Reflux oesophagitis (mild cases, OTC)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

H2 receptor antagonists: Drugs MoA Uses

A
  • Ranitidine
  • Cimeditine

Competitive inhibition of histamine actions at gastric H2 histamine receptors in parietal cells to decrease acid secretion by up to 90%

Used in:

  • Reflux oesophagitis (mild cases)

​Side Effects: Cimeditine inhibits many cytochrome P450 enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Proton Pump Inhibitors

Drugs

MoA

Uses

A
  • Lansoprazole
  • Omeprazole

Irreversible inhibition of H+/K+ ATPase pump in gastric parietal cells =decreased basal and stimulated acid secretion:

  • From the circulation, the pro-drug (lipophilic) traverses the parietal cell and enters the canaliculus.
  • In acidic canaliculus, drug is activated and trapped.
  • Drug binds to H+/K+-ATPase, irreversibly inactivating it.
  • For acid secretion to resume, new pump molecules have to be synthesized (2-3 days)

Used in:

  • GORD and Reflux Oesophagitis (all but mild cases)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What classes of drugs are used to treat disorders of acid secretion?

A
  • Antacids and alginates
  • Histamine H2-receptor antagonists
  • Proton pump inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why can NSAIDs cause peptic ulcers?

A

NSAIDs inhibit prostaglandin production by inhibiting cyclo-oxygenase enzyme. (Prostaglandins E2 and I2 stimulate gastric mucous and HCO3 production and inhibit gastric acid production)

Therefore impair renewal of the gastric mucosal barrier which is needed to prevent it from rapidly mixing with stomach contents allowing stomach acid to cause gastric erosions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Bulk Laxatives: Drugs MoA Uses

A
  • Methylcellulose
  • Isphagula Husk

Polysaccharide polymers not broken down by normal process of digestion. Retain water in the GI lumen, softening and increasing faecal bulk and promote increased motility. Act in 1-3 days.

Uses:

  • First line for constipation and IBS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Osmotic Laxatives: Drugs

A

Saline purgatives

Macrogol

Lactulose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Faecal Softeners: Drugs MoA Uses

A
  • Docusate
  • Arachis Oil (enema)

Stimulates water & electrolyte secretion into intestinal lumen; lower surface tension at oil-water interface allowing water and fat to enter stool cause it to soften. Act 3-5 days

Uses:

  • Constipation
  • Fissures
  • Piles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Stimulant Purgatives:

Drugs

MoA

Uses

A

Bisacodyl (usually suppository)

Stimulates rectal mucosa, resulting in mass movements and defaecation in 15-30 minutes Only short courses should be used

Uses:

  • Opioid related constipation.

Senna:

Passes unchanged into colon, where bacterial action releases free anthracene derivatives. Anthracene derivatives are absorbed and have a direct on myenteric plexus to increase intestinal motility (stronger muscle contractions)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which classes of drugs are purgatives?

A

Bulk laxatives

Osmotic laxatives

Faecal softeners

Stimulant purgatives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Osmotic laxatives: Saline purgatives

MoA

Uses

A
  • Mg sulphate
  • Mg hydroxide

Potent, rapid action (1-2 Bowel prep prior to procedure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Osmotic laxatives: Macrogols

MoA and uses

A

Inert polymers of ethylene glycol. Sequester fluid in the bowel

Uses:

  • Treatment of faecal impaction in children
  • Long-term management of chronic constipation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Osmotic laxatives: Lactulose MoA and uses

A

Semi-synthetic disaccharide of fructose and galactose- mimicks undigested lactose

Colonic bacteria convert it to its two component monosaccharides which are poorly absorbed. Fermentation yields lactic acid and acetic acid which function as osmotic laxatives.

Acts within 1-3 days

Uses:

  • Chronic constipation
  • Hepatic encephalopathy
  • Negating the constipating effects of opioids.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Oral Rehydration Therapy

A

Isotonic/hypotonic solution of glucose and sodium chloride

Exploits the ability of glucose to enhance the absorption of Na+ and therefore water

Uses:

  • Maintenance of fluid and electrolyte balance, rehydration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Opioid anti-motility agents

A
  • Loperamide
  • Codeine

Agonist for mu-opioid receptors in myenteric plexus; increases tone and rhythmic (haustral) contractions of the colon but diminishes propulsive activity. Blocks intestinal muscarinic receptors.

Uses:

  • Acute, uncomplicated diarrhoea in adults (adjunct to rehydration therapy)

Side Effects:

  • Constipation (chronic use)
  • Abdo cramps
  • Dizziness
  • Paralytic ileus can occur
17
Q

Loop Diuretics

Drugs

Moa

Uses

Side Effects

A
  • Furosemide
  1. Inhibits Na+/K+/2Cl- transporter (competes with Cl- binding) reducing NaCl reabsorption in the thick ascending LoH therefore decreased water absorption.
  2. Causes decreased osmotic concentration in the medulla therefore decreased ADH mediated H20 absorption.
  3. Increased delivery of NaCl to the DCT causes increased Na+ uptake by principal cells, causing loss of K+ and H+.
  4. Reduce calcium and magnesium absorption

Bind to plasma proteins, not filtered, but secreted directly into PCT so effective in renal impairment.

Uses:

  • Peripheral oedema
  • Acute pulmonary oedema
  • Resistant HTN.
  • Heart failure

Side Effects:

  • Hypovolaemia
  • Hypotension
  • Hyponatraemia/hypokalaemia
  • Ototoxicity (high doses)
18
Q

Thiazide diuretics

Drugs

MoA

Uses

Side Effects

A
  • Indapamide
  • Bendroflumethiazide
  • Hydrochlorothiazide
  • Chlortalidone

Inhibits Na+/Cl- co-transporter in early DCT (compete with Cl- binding) so increasing Na+ in lumen therefore water.

Filtered and secreted so not useful in renal impairment

Uses:

  • Peripheral oedema (chronic HF)
  • HTN

Side Effects:

  • Weak/moderate diuresis,
  • Hyponatraemia/hypokalaemia
  • Increased plasma uric acid (gout)
  • Erectile dysfunction
  • Hyperglycaemia
19
Q

Potassium-sparing diuretics: Aldosterone antagonists

Drugs

MoA

Uses

Side Effects

A
  • Spironolactone
  • Eplenerone

Aldosterone antagonist as binds to mineralocorticoid receptor in the late DCT/cortical collecting tubule. Prevents synthesis of ENaC and Na+/K+ATPase activation therefore reduced K+ secretion into the lumen (K+ retained) and reduced Na+ reabsorption and accompanying water.

Uses:

  • Chronic HF
  • Peripheral oedema
  • Ascites caused by liver cirrhosis
  • Hyperaldosteronism
  • Resistant HTN, in combination with loop/thiazide diuretics to prevent K+ loss.

SEs:

  • Hyperkalaemia
  • Gynaecomastia
20
Q

Potassium sparing diuretics: ENaC antagonists

A

Amiloride

Blockade of sodium reabsorption via ENaC channel (competes for Na binding site) therefore decreases luminal permeability to Na+. Causes reduced K+ secretion into the lumen, therefore K+ retained.

Used in combination to prevent K+ loss from use of loop/thiazide diuretics

Side Effects: hyperkalaemia

21
Q

Carbonic Anhydrase Inhibitors

A
  • Acetazolamide

Inhibit carbonic anhydrase in the PCT, preventing it from converting carbonic acid to water and CO2, therefore blocking the absorption of HCO3- and the accompanying sodium and water.

Uses:

  • Reduce intraocular pressure (e.g. glaucoma)
22
Q

Osmotic diuretics

A

Mannitol

Increases osmolality of glomerular filtrate preventing water reabsorption in the PCT and descending LoH Uses:

  • Decrease ICP and intraocular pressure in glaucoma
23
Q

Why do loop and thiazide diuretics cause hypokalaemia?

Why may alkalosis also occur alongside this?

A

They increase delivery of NaCl to the distal nephron and decrease blood volume.

This increases K+ secretion by:

  • Increasing tubular flow rate (K+ washes away creating high concentration gradient)
  • Increases activity of Na+/K+ATPase via increased Na+ therefore more K+ is secreted out of the cells
  • Activation of RAAS from decreased blood volume = increased aldosterone therefore more Na+ reabsorption in kidneys = more K+ secreted.

May also cause alkalosis as it can stimulate intercalated cells to secrete H+ so more acid is lost in urine.

24
Q

Renin Inhibitors

A

Aliskiren

Prevents renin from converting angiotensinogen to angiotensin I this inhibiting the action of the RAAS system on increasing BP

25
Q

Angiotensin converting enzyme (ACE) inhibitors

Drugs

MoA

Side Effects

A
  • Ramipril

Inhibits angiotensin converting enzyme, preventing it from converting angiotensin I to angiotensin II. This prevents it from inducing contraction in vascular smooth muscle and increasing BP.

Side effects:

  • Persistent cough
  • Hypotension
  • Decreased GFR as angiotensin normally constricts efferent arterioles
26
Q

Angiotensin II receptor antagonists (ARB)

A

Losartan

Blockade of cell signalling induced by angiotensin II. Binds to angiotensin II receptors preventing the RAAS system from raising BP.

27
Q

Aldosterone antagonist

A

Spironolactone

Blockade of mineralocorticoid activation preventing the RAAS system from increasing BP

28
Q

Thyroid hormones

A

Levothyroxine

  • Synthetic T4 (first line treatment)

Liothyronine

  • Synthetic T3, rapid, transient action (spikes)

Mimics thyroid hormone: acts on intracellular alpha and beta thyroid receptors.

Levothyroxine: longer half life

29
Q

Alpha-adrenergic blocker

A

Doxazosin

Selective alpha1 adrenergic receptor blocker in the bladder neck, urethra and prostate. Prevents sympathetic neurons from initiating smooth muscle contraction, causing relaxation which allows urinary flow.

Uses:

  • Urinary retention
  • BPH

Side Effects: blocks alpha1 receptors throughout body:-

  • Nausea
  • Dry mouth
  • Constipation
  • Anxiety
  • Back pain
  • Coughing
  • Dyspnoea
  • Fatigue
  • Myalgia
  • Paraesthesia
  • Vertigo
30
Q

Urinary anti-spasmodic: anticholinergic

A

Oxybutynin

Anticholinergic: competitively inhibits muscarinic (M2 & M3) receptors, blocking acetylcholine.

Reduces detrusor responsiveness and activity. Urge incontinence/ overactive bladder

Side Effects: blocks muscarinic receptors throughout body:

  • Dry mouth
  • Dry eyes
  • Constiption
  • Heartburn
  • Blurred vision
  • Glaucoma
  • Fatigue
  • Tachycardia
  • Urinary retention (not as effective at emptying)